Navigation Links
Sinobiopharma Presents Highlights from Unaudited First Quarter Financial Results for the 3 Month Period Ended August 31, 2009
Date:10/20/2009

NANTONG CITY, China, Oct. 21 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. (OCT Bulletin Board: SNBP) ("Sinobiopharma" or, the "Company") is pleased to present the following highlights from the unaudited financial results for the first quarter ended August 31, 2009.

The highlights feature record revenues and increases in both gross margin and net profit, and a Company milestone of posting its first overall net profitable quarter since the second quarter 2008, according to Dr. Lequn Lee Huang, Sinobiopharma President and CEO.

    -- Revenue increased to US $1,293,764 for the three months ended August 31,
       2009 from US $931,203 in the corresponding period ended August 31, 2008,
       an increase of 39%.

    -- Gross profit increased 57% to US $962,923, reflecting a 74% gross
       margin for the three months ended August 31, 2009.  This compares to US
       $612,428, and a 66% gross margin, reported for the corresponding period
       ended August 31, 2008.

    -- Net profit of the Company's wholly owned operating subsidiary, Dong
       Ying (Jiangsu) Pharmaceutical Co., Ltd., increased to US $561,292,
       representing 43% of sales revenue, for the three months ended August 31,
       2009 from US $218,031 in the corresponding period ended August 31, 2008,
       a year-over-year increase of more than 154%.

    -- With a net profit overall of US $237,167 for the three months ended
       August 31, 2009, the quarter marks the first time Sinobiopharma has
       moved from loss to net profitability.  During the quarter, the main
       expense affecting the net result was a stock-based compensation charge
       of US $324,125. The charge has been fully amortized in this quarter,
       reflecting the vesting of stock options granted by the Company.

    -- Growth in sales and the improvement in gross margin were both due to
       continued strong demand for of Cisatracurium Besylate, which
       contribute
'/>"/>
SOURCE Sinobiopharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
2. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
3. Sinobiopharma, Inc. Appoints New Director of Marketing
4. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
5. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
6. Sinobiopharma Secures Rights to Seven Key Patents
7. Sinobiopharma Announces SFDA Approval of Anti-Hypertension Drug Perindopril
8. Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009
9. Sinobiopharma Applies For Two Chinese Patents For Cisatracurium Besylate
10. Emissary Capital Group Initiates Coverage on Sinobiopharma
11. Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- New programme aims to help ... and chemical sectors Pfizer Asia Pacific ... Siemens Pte. Ltd, have signed on as founding ... - Innovative Processing of Specialties and Pharmaceuticals (iPSP). ... Sciences (ICES), the consortium offers a platform for ...
(Date:6/19/2013)... June 19, 2013 For an eco-friendly ... Waterless Bead Baths using metallic beads instead of ... and do not require germicides. Yet, the bead bath ... the bath is always ready unlike a water bath, ... a dry bath, which eliminates the contamination and maintenance ...
(Date:6/19/2013)... June 19, 2013 Bellevue city ... hall of technology solutions for people with disabilities ... Hyatt Regency Bellevue. , The exhibit hall, ... on Saturday and Sunday, will feature leading manufacturers ... wheelchairs, communication devices, eyegaze technologies, computer applications, and ...
(Date:6/19/2013)... An article posted earlier this week by Fox ... for probiotics. The article stated that while many products are ... beeb listed, the actual use for probiotics may go ... While the total uses of probiotics have not yet been ... these “miracle” bacterium, and debunked the myths surrounding them. ...
Breaking Biology Technology:Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall 2Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2
... Pharma, an emerging biotech,company focused on developing ... data demonstrating that its enzyme,replacement therapy (ERT) ... already been severely weakened by the disease. ... product ENB-0040, significantly,increases survival and prevents bone ...
... Commentary and How-To, Communications Tools; and ... ALTO, Calif., Sept. 15 Lena Chow, a ... has,launched a new website, http://www.cityofparis.us, to ... share thinking, gain insights and,connect with their peers. ...
... SHENYANG, China, Sept. 15 3SBio Inc. (Nasdaq:,SSRX), ... manufacturing and marketing biopharmaceutical products, today,announced the results ... General,Meeting of Shareholders held on September 12, 2008 ... meeting, the Company,s shareholders re-elected Dr. Jing Lou,Liping ...
Cached Biology Technology:Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 3
(Date:6/19/2013)... June 19, 2013   Mercy Medical ... diagnostics technology for conducting on-demand, Hemoglobin A ... as well as analysis of important red ... counts. The new system enables the hospital ... for physicians and their patients, which can ...
(Date:6/19/2013)... (SACRAMENTO, Calif.) A study of the patients ... fungus Exserohilum rostratum from the New England Compounding ... infections even though they did not experience a ... imaging (MRI) can help detect infection, especially among ... lots. , The study, along with an ...
(Date:6/19/2013)... Mass. In the cover story for the journal ... colleagues at the University of Massachusetts Amherst describe a ... to study the function of individual proteins in individual ... advance should allow deeper insights into protein function, Chase ... of what that single protein does when we isolate ...
Breaking Biology News(10 mins):Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 3Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 4Evolution of an outbreak: Complications from contaminated steroid injections 2UMass Amherst researchers develop powerful new technique to study protein function 2UMass Amherst researchers develop powerful new technique to study protein function 3
... to predict the impact of climate change on the dengue ... that could help limit its spread. According to ... Ecological Society,s journal Functional Ecology , climate change and ... mosquito,s range. But human behaviour in the form of ...
... 2009. The Alfred Wegener Institute for Polar and ... the ongoing Polarstern expedition LOHAFEX". Independent scientific and ... Education and Research and the Federal Ministry for ... that the iron fertilisation experiment LOHAFEX is neither ...
... leading provider of,embedded speech solutions today announced the ... AG, according to SVOX CEO Volker Jantzen.,SVOX has ... developed,over 25 years, including the SpeechAdvance(TM) speech recognition ... majority of the Professional,Speech Processing Group,s employees will ...
Cached Biology News:Hoarding rainwater could 'dramatically' expand range of dengue-fever mosquito 2Polarstern expedition 'LOHAFEX' can be conducted 2Polarstern expedition 'LOHAFEX' can be conducted 3SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog 2
UNIVERSAL SCORECARD DNA, 1 EA. * Category: Reagents/Consumables....
mitochondrial proteins (human heart) for 2-D gel electrophoresis *5 mg/mL*...
... GeneMaths XT is undoubtedly the most complete ... advanced concept of layers and subsets makes ... layers for different data outputs, for example ... etc., as well as different subsets of ...
...
Biology Products: